Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is located in San Diego, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus' scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.
Looking for a particular Regulus Therapeutics employee's phone or email?
The Regulus Therapeutics annual revenue was $6.3 million in 2026.
Brian Campion is the Vice President, Business Development of Regulus Therapeutics.
6 people are employed at Regulus Therapeutics.
Regulus Therapeutics is based in San Diego, California.
The NAICS codes for Regulus Therapeutics are [541711, 541, 54, 5417, 32, 325, 33, 54171].
The SIC codes for Regulus Therapeutics are [37, 87, 28, 283].